Establishment Labs Holdings Inc., (NASDAQ: ESTA), a US-based medical technology company specializing in women’s health, has announced the official market launch of its Motiva brand breast implants in China. The company’s product line includes the Motiva Flora tissue expander, which is designed to enhance the outcomes of breast reconstruction post-breast cancer surgery. Notably, the Motiva Flora is the only expander globally approved by regulatory bodies that features an integrated port with radio-frequency technology and is MR conditional.
According to the company’s press release, China stands as the second largest market worldwide for breast implants, with significant potential for growth.- Flcube.com
